NRSN
NeuroSense Therapeutics Ltd.
stockNASDAQ
At CloseOct 2, 2026 3:20:04 PM EDT
3.90USD-3.580%(-0.15)24,231
Pre-marketOct 2, 2026 8:53:30 AM EDT
3.90USD-3.704%(-0.15)
After-hoursOct 2, 2026 4:26:30 PM EDT
4.00USD+2.433%(+0.10)
Loading…
Loading…
7.50M
Healthcare
Biotechnology
HQ
Herzliya, Israel
Previous Close
$4.05
Beta
1.21
52-Week High
$26.64 2025-10-21
52-Week Low
$3.82 2026-10-02
SMA 50
$8.09
SMA 200
$14.31
Avg. Vol 10D
27,543
Avg. Vol 30D
26,326
Avg. Vol 90D
17,696
Relative Vol
0.92
1.90M
1.17M
61.48%
38,236
3.28%
1.00
37%/63%
51.89%
48.51%
12.6000%
3,000
3,358
2,045
9,070
Sep 14, 2026 · 1-for-20 (reverse)
Oct 2, 2026
NeuroSense Provides Update on Nasdaq Listing Compliance · 
PR Newswire
Sep 28, 2026
Sep 25, 2026
NeuroSense Therapeutics GAAP EPS of -$2.10 beats by $1.83 · 
Seeking Alpha
NRSN Profile
advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
NRSN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 5.10 | 2026-09-28 | -22.45% | 3.989 |
| 1M | 10.22 | 2026-09-04 | -61.29% | 6.701 |
| 3M | 13.92 | 2026-07-06 | -71.59% | 3.801 |
| 6M | 15.24 | 2026-04-06 | -74.05% | 1.877 |
| 1Y | 25.00 | 2025-10-03 | -84.18% | 1.211 |
| 2Y | 25.20 | 2024-10-04 | -84.31% | — |
| 5Y | 80.80 | 2021-12-09 | -95.11% | 0.659 |
NRSN Stock Summary
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $3.96, and today's volume is 24,231. NRSN is down 2.346% today. The 30 day average volume is 26,326. NRSN market cap is $7.50M with 1.90M shares outstanding.